Series B - LabGenius
Investment Firm
Overview
LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
Announced Date
May 21, 2024
Funding Type
Series B
Highlights
Location
Europe
Social
Participant Investors
8
Round Details and Background
LabGenius raised $44485456 on 2024-05-21 in Series B
LabGenius uses a machine learning-driven evolution engine to develop protein therapeutics.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 30, 2020 |  Series A - LabGenius | 5 | - | 15.0M |
| Sep 11, 2019 | Series A - LabGenius | 1 | - | undefined |
| Oct 07, 2022 | Grant - LabGenius | 1 | - | undefined |
| May 21, 2024 | Series B - LabGenius | 8 | - | 44.5M |
Recent Activity
There is no recent news or activity for this profile.